BreakVax (BB-101) - BreakBio Corp
Recombinant Human Thrombomodulin Derivative Promotes Wound Healing in Diabetic Foot Ulcer by Modulating VEGF-dependent Angiogenesis and Extracellular Matrix Organization Pathway (ESDR 2026) - Sep 9, 2026 - Abstract #348; Pres time: Sep 10, 2026; 11:30 AM - 01:00 PM; Location: Hall 2A; "Our findings suggested that rhTM derivative, BB-101, accelerated wound healing process and activated key regenerative pathways. This molecule represents a promising candidate for the development of new DFU therapies, offering an additional option with the potential to overcome the challenges of existing treatments." 
Diabetes • Metabolic Disorders
https://esdrmeeting.org/wp-content/uploads/2026/09/20260905-ESDR-Abstract-Book_web.pdf
 
Jiun-Yan Ding 1; Yu-Qi Chuang 2; Thi Quynh Trang Dao 1; Hua-Lin Wu 3; Chien-Chen Lin 1,2
 
Sep 9, 2026
 
Next